{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:47:54Z","timestamp":1771472874439,"version":"3.50.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0081492","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T21:22:34Z","timestamp":1386710554000},"page":"e81492","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["In Vitro Susceptibilities of Wild and Drug Resistant Leishmania donovani Amastigote Stages to Andrographolide Nanoparticle: Role of Vitamin E Derivative TPGS for Nanoparticle Efficacy"],"prefix":"10.1371","volume":"8","author":[{"given":"Subhasish","family":"Mondal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvadra","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Halder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arup","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanmoy","family":"Bera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"key":"ref1","first-page":"125","article-title":"Biological activities of <italic>Kalmegh<\/italic> (<italic>Andrographis paniculata<\/italic> Nees) and its active principles- A review","volume":"1","author":"A Niranjan","year":"2010","journal-title":"Ind J Natural Products Resource"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/13880209209054010","article-title":"Antimalarial Activity of <italic>Andrographis paniculata (Kalmegh)<\/italic> against <italic>Plasmodium berghei<\/italic> NK 65 in <italic>Mastomys natalensis<\/italic>","volume":"30","author":"P Misra","year":"1992","journal-title":"Pharm Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/107175400455137","article-title":"Targeting of liposomal andrographolide to <italic>L. donovani<\/italic>-infected macrophages <italic>in vivo<\/italic>","volume":"7","author":"J Sinha","year":"2000","journal-title":"Drug Deliv"},{"key":"ref4","first-page":"169","article-title":"Delivery <italic>in vivo<\/italic> of 14-deoxy-11oxoandrographolide, an antileishmanial agent, by different drug carriers","volume":"40","author":"S Lala","year":"2003","journal-title":"Indian J Biochem Biophys"},{"key":"ref5","first-page":"266","article-title":"Distribution and excretion of [<sup>35<\/sup>S] NaHSO<sub>3<\/sub>\u2013andrographolide by autoradiography","volume":"2","author":"SP Zhu","year":"1981","journal-title":"Acta Pharmacologica Sinica"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1016\/j.biomaterials.2012.03.046","article-title":"Vitamin E TPGS as a molecular biomaterial for drug delivery","volume":"33","author":"Z Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.biomaterials.2004.07.050","article-title":"Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs","volume":"26","author":"KY Win","year":"2005","journal-title":"Biomaterials"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s11095-008-9611-6","article-title":"<italic>In vitro<\/italic> and <italic>in vivo<\/italic> investigation on PLATPGS nanoparticles for controlled and sustained small molecule chemotherapy","volume":"25","author":"ZP Zhang","year":"2008","journal-title":"Pharm Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biomaterials.2005.05.104","article-title":"Nanoparticles of poly(lactide)\/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and <italic>in vitro<\/italic> drug release","volume":"27","author":"ZP Zhang","year":"2006","journal-title":"Biomaterials"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20040283","article-title":"Reduction of antileishmanial pentavalent antimonial drugs by a parasite-specific thiol\u2013dependent reductase, TDR1","volume":"381","author":"H Denton","year":"2004","journal-title":"Biochem J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"37445","DOI":"10.1074\/jbc.M404383200","article-title":"<italic>Leishmania major<\/italic> LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug Pentostam","volume":"279","author":"Y Zhou","year":"2004","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1023\/A:1022823605068","article-title":"Thiol-induced reduction of antimony (V) into antimony (III) : a comparative study with trypanothione, cysteinyl-glycine, cysteine and glutathione","volume":"16","author":"C Santos Ferreira","year":"2003","journal-title":"Biometals"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijpara.2011.07.013","article-title":"Characterization of antimony-resistant <italic>Leishmania donovani<\/italic> isolates : Biochemical and biophysical studies and interaction with host cells","volume":"41","author":"R Mukhopadhyay","year":"2011","journal-title":"Int J Parasitol"},{"key":"ref14","unstructured":"Garcia-Hernander R, Manzano SI, Castanys S, Gamarro F (2012) <italic>Leishmania donovani<\/italic> develops resistance to drug combinations. Plos Negl Trop Dis 6: e 1974."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2005.02.009","article-title":"Functional expression of a multidrug P-glycoprotein transporter of <italic>Leishmania.<\/italic>","volume":"329","author":"F Cortes-Selva","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-60761-416-6_10","article-title":"Expression and function of P-glycoprotein in normal tissues : effect on pharmacokinetics","volume":"596","author":"F Stand","year":"2010","journal-title":"Methods Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11095-007-9347-8","article-title":"Natural and synthetic polymers as inhibitors of drug efflux pumps","volume":"25","author":"M Werle","year":"2008","journal-title":"Pharm Res"},{"key":"ref18","first-page":"1113","article-title":"Andrographolide nanoparticles in leishmaniasis: characterization and <italic>in vitro<\/italic> evaluations","volume":"5","author":"P Roy","year":"2010","journal-title":"Int J Nanomed"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s11095-012-0964-5","article-title":"Engineered andrographolide nanoparticles mitigate paracetamol hepatotoxicity in mice","volume":"30","author":"P Roy","year":"2013","journal-title":"Pharm Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molbiopara.2011.06.004","article-title":"Differential expression of proteins in antimony-susceptible and resistant isolates of <italic>Leishmania donovani.<\/italic>","volume":"179","author":"N Biyani","year":"2011","journal-title":"Mol Biochem Parasitol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.2008.79.69","article-title":"Role of aquaglyceroprorin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of <italic>Leishmania donovani<\/italic>","volume":"79","author":"M Maharjan","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/jac\/dkp468","article-title":"Assesing aquaglyceroporin gene status and expression profile in antimony\u2013susceptible and resistant clinical isolates of <italic>Leishmania donovani<\/italic> from India","volume":"65","author":"S Mondal","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jac\/dkl494","article-title":"Role of ABC transporter MRPA, gamma 454 glutamylcystiene synthetase and ornithine decarboxylase in natural antimony-resistant isolates of <italic>Leishmania donovani<\/italic>","volume":"59","author":"A Mukherjee","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.01196-07","article-title":"Inhibition of ABC transporters abolishes antimony resistance in <italic>Leishmania<\/italic> infection","volume":"52","author":"JM Basu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2307\/3281131","article-title":"High efficiency plating method for <italic>Leishmania<\/italic> promastigotes in semi-defined or completely-defined media","volume":"69","author":"DM Iovannisci","year":"1983","journal-title":"J Parasitol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1550-7408.1990.tb01147.x","article-title":"<italic>Leishmania donovani<\/italic> : a chemically defined medium suitable for cultivation and cloning of promastigotes and transformation of amastigotes to promastigotes","volume":"37","author":"K Kar","year":"1990","journal-title":"J Protozool"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.colsurfb.2013.01.061","article-title":"One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis","volume":"107","author":"S Das","year":"2013","journal-title":"Colloids Surfaces B: Biointerfaces"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpara.2003.10.011","article-title":"Generation of <italic>Leishmania donovani<\/italic> axenic amastigotes : their growth and biological characteristics","volume":"34","author":"A Debrabant","year":"2004","journal-title":"Int J Parasitol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.41.5.972","article-title":"Axenically cultured amastigote forms as an <italic>in vitro<\/italic> model for investigation of antileishmanial agents","volume":"41","author":"D Senero","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A comparision of the methods of estimating EC<sub>50<\/sub> in studies of drug resistance of malaria parasites","volume":"55","author":"W Huber","year":"1993","journal-title":"Acta Trop"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"S Nwaka","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijpharm.2006.11.061","article-title":"Haloperidol-loaded PLGA nanoparticles: Systemic study of particle size and drug content","volume":"336","author":"A Budhian","year":"2007","journal-title":"Int J Pharm"},{"key":"ref33","first-page":"107","article-title":"A method for the preparation of polymeric nanocapsules without stabilizer, J Control Release","volume":"61","author":"Z Lu","year":"1999"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.colsurfa.2011.10.012","article-title":"Surface modification of poly (lactide-co-glycolide) nanoparticles by d-\u03b1-tocopheryl polyethylene glycol 1000 succinate as potential carrier for the delivery of drugs to the brain. Colloids and Surfaces A: Physicochem","volume":"392","author":"N Jalali","year":"2011","journal-title":"Eng Aspects"},{"key":"ref35","first-page":"3547","article-title":"A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants","volume":"7","author":"A Xu","year":"2012","journal-title":"Int J Nanomed"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","article-title":"Mechanism of solute release from porous hydrophilic polymers","volume":"15","author":"RW Korsemeyer","year":"1983","journal-title":"Int J Pharm"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0168-3659(02)00260-2","article-title":"Study of release kinetics of small and high molecular weight substances dispersed into spray-dried ethylcellulose microspheres","volume":"84","author":"N Grattard","year":"2002","journal-title":"J Control Rel"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL : the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"H Gelderblom","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2005.11.005","article-title":"Influence of vitamin E TPGS poly(ethylene glycol) chain lenth on apical efflux transporters in Caco-2 cell monolayers","volume":"111","author":"EM Collnot","year":"2006","journal-title":"J Control Release"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1021\/mp060121r","article-title":"Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS : influence on ATPase activity and membrane fluidity","volume":"4","author":"EM Collnot","year":"2007","journal-title":"Mol Pharm"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1573413052953110","article-title":"Nanosystems in drug targeting: Opportunities and challenges","volume":"1","author":"JK Vasir","year":"2005","journal-title":"Curr Nanosci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2013current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"SL Croft","year":"2003","journal-title":"Trends Parasitol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2007.09.013","article-title":"Nano\/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives","volume":"125","author":"RC Mundargi","year":"2008","journal-title":"J Control Release"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0081492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T19:17:26Z","timestamp":1564946246000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0081492"}},"subtitle":[],"editor":[{"given":"Abhay R.","family":"Satoskar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0081492","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]}}}